1. Anti-calculus activity of a toothpaste with microgranules
- Author
-
P.R. Jones, Denis O'Mullane, A Finnerty, R.K. Chesters, and E Huntington
- Subjects
Adult ,Male ,business.product_category ,Adolescent ,Dentistry ,Citric Acid ,law.invention ,Outcome variable ,Randomized controlled trial ,law ,Calculus ,medicine ,Humans ,Dental Calculus ,Single-Blind Method ,Zinc Citrate Trihydrate ,Particle Size ,General Dentistry ,Lower anterior ,Analysis of Variance ,Toothpaste ,business.industry ,Calculus (dental) ,medicine.disease ,Two phase design ,Triclosan ,Otorhinolaryngology ,Zinc Compounds ,Female ,Analysis of variance ,business ,Toothpastes - Abstract
OBJECTIVE: The objective of the trial was to determine the efficacy of the proven anticalculus active system (zinc citrate trihydrate [ZCT] and triclosan), when the ZCT is delivered from microgranules incorporated in a silica-based toothpaste containing 1450 ppm F as sodium fluoride. DESIGN: A monadic, single-blind, two phase design clinical trial was used to compare the effect of the test and a negative control fluoridated toothpaste on the formation of supragingival calculus. SUBJECTS AND METHODS: Male and female calculus-forming volunteers, aged 18 or over, were recruited for the study following a 2-week screening phase. All subjects were given a scale and polish of their eight lower anterior teeth at the start of both the pre-test and test phases. Subjects were supplied with a silica-based 1450 F ppm fluoridated toothpaste with no anti-calculus active for use during an 8-week pre-test phase. Calculus was assessed at the end of the pre-test and test phases using the Volpe-Manhold index (VMI). Subjects were stratified according to their pre-test VMI score (8–10, 10.5–12, > 12) and gender and then allocated at random to test or negative control toothpaste groups. Subjects with < 8 mm of calculus were excluded from further participation. MAIN OUTCOME MEASURE: The outcome variable was the mean VMI score for the test and negative control groups. RESULTS: The test toothpaste caused a statistically significant 30% reduction in calculus compared with the control paste after a 13-week use. No adverse events were reported during the study. CONCLUSION: The incorporation of the ZCT in microgranules did not adversely affect the anticalculus activity of the new formulation.
- Published
- 2008
- Full Text
- View/download PDF